IBJNews

Regenstrief names new CEO

Back to TopCommentsE-mailPrintBookmark and Share

The Regenstrief Institute Inc. will have a new CEO Oct. 1 as Dr. Bill Tierney replaces Dr. Tom Inui.

Inui, who has led the medical research institute since 2002, will remain a Regenstrief rersearcher focused on global health issues.

Tierney, 59, has spent his entire 30-year career at Regenstrief, which developed one of the nation’s first electronic medical record systems and maintains 35 years of patient data from that system.

The Regenstrief database lies behind the Indiana Health Information Exchange, an Indianapolis-based not-for-profit group, which facilitates the swapping of patient records between central Indiana hospitals. It is now trying to expand such record exchanges statewide.

Like most Regenstrief researchers, Dr. Tierney also teaches as the Indiana University School of Medicine and sees patients for Wishard Health Services, where he also acts as chief of medicine.

Tierney also led a team in developing an open-source medical resource system for AIDS clinics IU operates in Kenya. That system, called OpenMRS, is now being used widely in developing nations.

As part of his promotion, the IU School of Medicine has also named Tierney associate dean of clinical effectiveness research, a new position. The appointment still requires the approval of the IU trustees.

In a statement, Tierney said, “Building upon the 35 years of data of the Regenstrief Medical Record System and decades of groundbreaking health services and aging research, the Institute has an enormous opportunity to lead a revolution in healthcare systems and delivery of health care both in the United States and globally.”

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT